The Impact of COVID-19 on the Conduct of Clinical Trials for Medical Products in Korea

BACKGROUND: The number of clinical trials conducted in Korea continues to increase and an increasing proportion focus on severe and rare incurable diseases. After the start of the severe acute respiratory syndrome, coronavirus disease 2019 (COVID-19), Korea Centers for Disease Control and Prevention...

Descripción completa

Detalles Bibliográficos
Autores principales: Jeon, JuYeun, Kim, Hyeikyoung, Yu, Kyung-Sang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Academy of Medical Sciences 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7490200/
https://www.ncbi.nlm.nih.gov/pubmed/32924344
http://dx.doi.org/10.3346/jkms.2020.35.e329

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7490200/
https://www.ncbi.nlm.nih.gov/pubmed/32924344
http://dx.doi.org/10.3346/jkms.2020.35.e329

Ejemplares similares